Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Vaccine
|
October 15, 2010
In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization
Christine M Barbon, Lisa Baker, Christa Lajoie, et al.
Journal of Neuroinflammation
|
March 11, 2025
Fidgetin-like 2 knockdown increases acute neuroinflammation and improves recovery in a rat model of spinal cord injury
Austin N Smith, Samantha Nagrabski, Lisa Baker, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 18, 2011
Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers
Michael G Kelly, Gil Mor, Alan Husband, et al.
Nature Chemistry
|
February 22, 2017
Dynamic undocking and the quasi-bound state as tools for drug discovery
Sergio Ruiz-Carmona, Peter Schmidtke, F Javier Luque, et al.
American Journal of Speech-Language Pathology
|
August 25, 2021
Establishing Clinical Swallowing Assessment Services via Telepractice: A Multisite Implementation Evaluation
Elizabeth C Ward, Clare L Burns, Amy Gray, et al.
Journal of Telemedicine and Telecare
|
October 22, 2019
Implementation of speech pathology telepractice services for clinical swallowing assessment: An evaluation of service outcomes, costs and consumer satisfaction
Clare L Burns, Elizabeth C Ward, Amy Gray, et al.
JCI Insight
|
April 19, 2021
Fidgetin-like 2 negatively regulates axonal growth and can be targeted to promote functional nerve regeneration
Lisa Baker, Moses Tar, Adam H Kramer, et al.
Translational Vision Science & Technology
|
January 29, 2021
A Novel Therapeutic Approach to Corneal Alkaline Burn Model by Targeting Fidgetin-Like 2, a Microtubule Regulator
Jessie Wang, Abhinav Dey, Adam H Kramer, et al.
Oncotarget
|
October 6, 2015
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design
Andrew J Massey, Stephen Stokes, Helen Browne, et al.
Oncotarget
|
November 19, 2014
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells
Jonathan D Moore, Anna Staniszewska, Terence Shaw, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Vaccine
|
October 15, 2010
In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization
Christine M Barbon, Lisa Baker, Christa Lajoie, et al.
Journal of Neuroinflammation
|
March 11, 2025
Fidgetin-like 2 knockdown increases acute neuroinflammation and improves recovery in a rat model of spinal cord injury
Austin N Smith, Samantha Nagrabski, Lisa Baker, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 18, 2011
Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers
Michael G Kelly, Gil Mor, Alan Husband, et al.
Nature Chemistry
|
February 22, 2017
Dynamic undocking and the quasi-bound state as tools for drug discovery
Sergio Ruiz-Carmona, Peter Schmidtke, F Javier Luque, et al.
American Journal of Speech-Language Pathology
|
August 25, 2021
Establishing Clinical Swallowing Assessment Services via Telepractice: A Multisite Implementation Evaluation
Elizabeth C Ward, Clare L Burns, Amy Gray, et al.
Journal of Telemedicine and Telecare
|
October 22, 2019
Implementation of speech pathology telepractice services for clinical swallowing assessment: An evaluation of service outcomes, costs and consumer satisfaction
Clare L Burns, Elizabeth C Ward, Amy Gray, et al.
JCI Insight
|
April 19, 2021
Fidgetin-like 2 negatively regulates axonal growth and can be targeted to promote functional nerve regeneration
Lisa Baker, Moses Tar, Adam H Kramer, et al.
Translational Vision Science & Technology
|
January 29, 2021
A Novel Therapeutic Approach to Corneal Alkaline Burn Model by Targeting Fidgetin-Like 2, a Microtubule Regulator
Jessie Wang, Abhinav Dey, Adam H Kramer, et al.
Oncotarget
|
October 6, 2015
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design
Andrew J Massey, Stephen Stokes, Helen Browne, et al.
Oncotarget
|
November 19, 2014
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells
Jonathan D Moore, Anna Staniszewska, Terence Shaw, et al.
Page
of 5